CYP51A1 activators are compounds that specifically interact with the enzyme CYP51A1, also known as lanosterol 14-alpha-demethylase, which plays a crucial role in the biosynthesis of sterols. This enzyme is a member of the cytochrome P450 superfamily, a large and diverse group of enzymes that catalyze the oxidation of organic substances. CYP51A1 is highly conserved across different species, signifying its fundamental role in cellular processes. The enzyme is embedded in the membrane of the endoplasmic reticulum and is involved in the removal of methyl groups from lanosterol, which is a key step in the conversion of lanosterol to ergosterol in fungi and to cholesterol in animals. Activators of this enzyme influence its catalytic activity, enhancing its natural function within the sterol biosynthesis pathway. By binding to the active site or allosteric sites on the enzyme, these activators can modulate the enzyme's conformation and, consequently, its activity.
The precise mechanism by which CYP51A1 activators exert their effect can vary depending on the chemical structure of the activator and the nature of its interaction with the enzyme. Some activators may directly interact with the catalytic site of the enzyme, leading to an increased affinity for the enzyme's natural substrates. Others might bind to alternative regulatory sites on the enzyme, leading to conformational changes that result in an enhanced catalytic turnover rate. This modulation of enzyme activity can have profound effects on the concentration of various sterols within cells, as it alters the rate at which they are synthesized from precursors. The chemical characteristics of CYP51A1 activators are diverse, reflecting the versatility of the cytochrome P450 enzymes in accommodating various substrates and ligands. This diversity is also indicative of the complex regulation of sterol synthesis, which is critical to maintaining cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fluconazole | 86386-73-4 | sc-205698 sc-205698A | 500 mg 1 g | $54.00 $84.00 | 14 | |
Inhibits fungal CYP51, but in doing so, it may upregulate the human CYP51A1 homolog as a compensatory mechanism in fungi, potentially leading to increased sterol synthesis in human cells. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Antifungal agent that inhibits CYP51A1's fungal counterpart, possibly triggering a feedback loop that enhances the expression and activity of human CYP51A1 to maintain cholesterol homeostasis. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $78.00 $142.00 | 23 | |
Targets fungal CYP51 enzyme; its interaction with fungal systems could lead to a compensatory response in human CYP51A1 to balance cholesterol biosynthesis. | ||||||
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $66.00 $160.00 | 2 | |
Primarily used as an antifungal agent, it can indirectly affect the endogenous CYP51A1 by inhibiting the fungal version, suggesting a possible compensatory increase in CYP51A1 activity in human cells. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $42.00 $57.00 | 6 | |
Through its antifungal action on CYP51, clotrimazole may cause a compensatory upregulation of CYP51A1 to maintain essential sterol production. | ||||||
Econazole | 27220-47-9 | sc-279013 | 5 g | $240.00 | ||
An antifungal that inhibits ergosterol synthesis via fungal CYP51, which may lead to indirect enhancement of human CYP51A1 activity as a compensatory mechanism. | ||||||
Posaconazole | 171228-49-2 | sc-212571 | 1 mg | $353.00 | 7 | |
Similar to other azoles, posaconazole targets fungal CYP51, potentially leading to an indirect increase in CYP51A1 activity due to compensatory mechanisms. | ||||||
Allicin | 539-86-6 | sc-202449 sc-202449A | 1 mg 5 mg | $489.00 $1557.00 | 7 | |
A compound found in garlic that can influence various cytochrome P450 enzymes, potentially leading to an increase in CYP51A1 activity due to altered cholesterol metabolism. | ||||||
25-Hydroxycholesterol | 2140-46-7 | sc-214091B sc-214091 sc-214091A sc-214091C | 5 mg 10 mg 25 mg 100 mg | $53.00 $91.00 $169.00 $474.00 | 8 | |
An oxysterol that regulates cholesterol homeostasis and may modulate CYP51A1 as part of feedback control mechanisms in cholesterol biosynthesis. | ||||||
7-Ketocholesterol | 566-28-9 | sc-210630 | 5 mg | $99.00 | 5 | |
An oxidized form of cholesterol that can act as a signaling molecule, potentially influencing the activity of CYP51A1 as part of the cellular response to altered sterol levels. | ||||||